SONOPHORESIS SMARTPATCH Sonophoresis smartpatch for pain-free, controllable, and wearable transdermal drug delivery
- Coordinator
- Medicsensors SL, Spain
- Runs
- 1 August 2023 to 31 May 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €3.8m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190189473
What the project is doing
In the project's own words, from its summary on CORDIS.
Wearable SmartPatch is a unique needle-free drug delivery solution, based on a patented electronic system, that opens skin pores temporarily to deliver macromolecular drugs. It generates sound waves (Sonophoresis) that increase the size of the skin pores without pain or damage and passes drugs like insulin, heparin, or EPO (>50KDa) through, reaching the hypodermis and capillary vessels, without altering the pharmacokinetic profile of the drug.
It has a durable part with 3-year warranty including the ultrasound generator, electronics, and battery, and a disposable and recyclable piece that encloses the adhesive and the drug reservoir with up to 2mL (average for 3 days of treatment), changeable in less than 2 minutes. The device can vary both the absorption rate and the depth reached depending on programmed stimulation parameters, which allows adaptation to different skin types and therapeutic uses.
Our tests have shown absorption rates of at least 0,05 mL/minute on a 1 cm2 pig skin area
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Medicsensors SL | Madrid | Spain | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI